Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Fearon, DT; Manders, P; Wagner, SD
   Arrested differentiation, the self-renewing memory lymphocyte, and vaccination
   SCIENCE
   
   D.T. Fearon et al., "Arrested differentiation, the self-renewing memory lymphocyte, and vaccination", SCIENCE, 293(5528), 2001, pp. 248-250
2. de Fougerolles, AR; Batista, F; Johnsson, E; Fearon, DT
   IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19
   EUROPEAN JOURNAL OF IMMUNOLOGY
   
   A.R. de Fougerolles et al., "IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19", EUR J IMMUN, 31(7), 2001, pp. 2189-2199
3. Fearon, DT
   Innate immunity and instruction of the adaptive immune response
   THERAPEUTIC IMMUNOLOGY, SECOND EDITION
   
   D.T. Fearon, "Innate immunity and instruction of the adaptive immune response", THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 18-27
4. Fearon, DT
   Innate immunity - beginning to fulfill its promise?
   NATURE IMMUNOLOGY
   
   D.T. Fearon, "Innate immunity - beginning to fulfill its promise?", NAT IMMUNOL, 1(2), 2000, pp. 102-103
5. Bendelac, A; Fearon, DT
   Innate immunity - Receptors and effecters of innate immunity - Editorial overview
   CURRENT OPINION IN IMMUNOLOGY
   
   A. Bendelac e D.T. Fearon, "Innate immunity - Receptors and effecters of innate immunity - Editorial overview", CURR OP IM, 12(1), 2000, pp. 11-12
6. Fearon, DT; Carroll, MC
   Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
   ANNUAL REVIEW OF IMMUNOLOGY
   
   D.T. Fearon e M.C. Carroll, "Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex", ANN R IMMUN, 18, 2000, pp. 393-422
7. Smith, KGC; Fearon, DT
   Receptor modulators of B-cell receptor signalling - CD19/CD22
   SIGNAL TRANSDUCTION AND THE COORDINATION OF B LYMPHOCYTE DEVELOPMENT AND FUNCTION I
   
   K.G.C. Smith e D.T. Fearon, "Receptor modulators of B-cell receptor signalling - CD19/CD22", CURR T MICR, 245, 2000, pp. 195-212
8. Reljic, R; Wagner, SD; Peakman, LJ; Fearon, DT
   Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6
   JOURNAL OF EXPERIMENTAL MEDICINE
   
   R. Reljic et al., "Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6", J EXP MED, 192(12), 2000, pp. 1841-1847
9. Allison, MED; Fearon, DT
   Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunity
   EUROPEAN JOURNAL OF IMMUNOLOGY
   
   M.E.D. Allison e D.T. Fearon, "Enhanced immunogenicity of aldehyde-bearing antigens: a possible link between innate and adaptive immunity", EUR J IMMUN, 30(10), 2000, pp. 2881-2887
10. Fearon, DT
    Innate immunity and the biological relevance of the acquired immune response
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    D.T. Fearon, "Innate immunity and the biological relevance of the acquired immune response", QJM-MON J A, 92(5), 1999, pp. 235-237
11. Hammel, JM; Elfeki, SK; Kobayashi, N; Ito, M; Cai, J; Fearon, DT; Graham, FL; Fox, IJ
    Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection
    TRANSPLANTATION PROCEEDINGS
    
    J.M. Hammel et al., "Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection", TRANSPLAN P, 31(1-2), 1999, pp. 939-939
12. OROURKE LM; TOOZE R; TURNER M; SANDOVAL DM; CARTER RH; TYBULEWICZ VLJ; FEARON DT
    CD19 AS A MEMBRANE-ANCHORED ADAPTER PROTEIN OF B-LYMPHOCYTES - COSTIMULATION OF LIPID AND PROTEIN-KINASES BY RECRUITMENT OF VAV
    Immunity
    
    L.M. Orourke et al., "CD19 AS A MEMBRANE-ANCHORED ADAPTER PROTEIN OF B-LYMPHOCYTES - COSTIMULATION OF LIPID AND PROTEIN-KINASES BY RECRUITMENT OF VAV", Immunity, 8(5), 1998, pp. 635-645
13. FEARON DT
    THE COMPLEMENT-SYSTEM AND ADAPTIVE IMMUNITY
    Seminars in immunology
    
    D.T. Fearon, "THE COMPLEMENT-SYSTEM AND ADAPTIVE IMMUNITY", Seminars in immunology, 10(5), 1998, pp. 355-361
14. FEARON DT
    INTEGRATING INNATE AND ACQUIRED IMMUNE RECOGNITION
    Molecular immunology
    
    D.T. Fearon, "INTEGRATING INNATE AND ACQUIRED IMMUNE RECOGNITION", Molecular immunology, 35(11-12), 1998, pp. 655-655
15. TUTT AL; FRENCH RR; ILLIDGE TM; HONEYCHURCH J; MCBRIDE HM; PENFOLD CA; FEARON DT; PARKHOUSE RME; KLAUS GGB; GLENNIE MJ
    MONOCLONAL-ANTIBODY THERAPY OF B-CELL LYMPHOMA - SIGNALING ACTIVITY ON TUMOR-CELLS APPEARS MORE IMPORTANT THAN RECRUITMENT OF EFFECTORS
    The Journal of immunology (1950)
    
    A.L. Tutt et al., "MONOCLONAL-ANTIBODY THERAPY OF B-CELL LYMPHOMA - SIGNALING ACTIVITY ON TUMOR-CELLS APPEARS MORE IMPORTANT THAN RECRUITMENT OF EFFECTORS", The Journal of immunology (1950), 161(6), 1998, pp. 3176-3185
16. SMITH KGC; TARLINTON DM; DOODY GM; HIBBS ML; FEARON DT
    INHIBITION OF THE B-CELL BY CD22 - A REQUIREMENT FOR LYN
    The Journal of experimental medicine
    
    K.G.C. Smith et al., "INHIBITION OF THE B-CELL BY CD22 - A REQUIREMENT FOR LYN", The Journal of experimental medicine, 187(5), 1998, pp. 807-811
17. TOOZE RM; DOODY GM; FEARON DT
    COUNTERREGULATION BY THE CORECEPTORS CD19 AND CD22 OF MAP KINASE ACTIVATION BY MEMBRANE IMMUNOGLOBULIN
    Immunity
    
    R.M. Tooze et al., "COUNTERREGULATION BY THE CORECEPTORS CD19 AND CD22 OF MAP KINASE ACTIVATION BY MEMBRANE IMMUNOGLOBULIN", Immunity, 7(1), 1997, pp. 59-67
18. OROURKE L; TOOZE R; FEARON DT
    CO-RECEPTORS OF B-LYMPHOCYTES
    Current opinion in immunology
    
    L. Orourke et al., "CO-RECEPTORS OF B-LYMPHOCYTES", Current opinion in immunology, 9(3), 1997, pp. 324-329
19. BENDELAC A; FEARON DT
    INNATE IMMUNITY - INNATE PATHWAYS THAT CONTROL ACQUIRED-IMMUNITY
    Current opinion in immunology
    
    A. Bendelac e D.T. Fearon, "INNATE IMMUNITY - INNATE PATHWAYS THAT CONTROL ACQUIRED-IMMUNITY", Current opinion in immunology, 9(1), 1997, pp. 1-3
20. ASIMAKOPOULOS FA; HINSHELWOOD S; GILBERT JGR; DELIBRIAS CC; GOTTGENS B; FEARON DT; GREEN AR
    THE GENE ENCODING HEMATOPOIETIC-CELL PHOSPHATASE (SHP-1) IS STRUCTURALLY AND TRANSCRIPTIONALLY INTACT IN POLYCYTHEMIA-VERA
    Oncogene
    
    F.A. Asimakopoulos et al., "THE GENE ENCODING HEMATOPOIETIC-CELL PHOSPHATASE (SHP-1) IS STRUCTURALLY AND TRANSCRIPTIONALLY INTACT IN POLYCYTHEMIA-VERA", Oncogene, 14(10), 1997, pp. 1215-1222
21. TABEI I; ELFEKI SG; NAKAMURA J; HAMMEL JM; FEARON DT; GRAHAM F; FOX IJ
    CONSTRUCTION, FUNCTION AND IN-VIVO EXPRESSION OF A COMPLEMENT RECEPTOR-TYPE-1 CONTAINING RECOMBINANT ADENOVIRUS FOR USE IN XENOTRANSPLANTATION
    Transplantation proceedings
    
    I. Tabei et al., "CONSTRUCTION, FUNCTION AND IN-VIVO EXPRESSION OF A COMPLEMENT RECEPTOR-TYPE-1 CONTAINING RECOMBINANT ADENOVIRUS FOR USE IN XENOTRANSPLANTATION", Transplantation proceedings, 29(1-2), 1997, pp. 933-934
22. FEARON DT
    SEEKING WISDOM IN INNATE IMMUNITY
    Nature
    
    D.T. Fearon, "SEEKING WISDOM IN INNATE IMMUNITY", Nature, 388(6640), 1997, pp. 323-324
23. FEARON DT
    INNATE AND ACQUIRED-IMMUNITY
    Nature
    
    D.T. Fearon, "INNATE AND ACQUIRED-IMMUNITY", Nature, 388(6640), 1997, pp. 323-323
24. CARTER RH; DOODY GM; BOLEN JB; FEARON DT
    MEMBRANE IGM-INDUCED TYROSINE PHOSPHORYLATION OF CD19 REQUIRES A CD19DOMAIN THAT MEDIATES ASSOCIATION WITH COMPONENTS OF THE B-CELL ANTIGEN RECEPTOR COMPLEX
    The Journal of immunology
    
    R.H. Carter et al., "MEMBRANE IGM-INDUCED TYROSINE PHOSPHORYLATION OF CD19 REQUIRES A CD19DOMAIN THAT MEDIATES ASSOCIATION WITH COMPONENTS OF THE B-CELL ANTIGEN RECEPTOR COMPLEX", The Journal of immunology, 158(7), 1997, pp. 3062-3069
25. DELIBRIAS CC; FLOETTMANN JE; ROWE M; FEARON DT
    DOWN-REGULATED EXPRESSION OF SHP-1 IN BURKITT-LYMPHOMAS AND GERMINAL CENTER B-LYMPHOCYTES
    The Journal of experimental medicine
    
    C.C. Delibrias et al., "DOWN-REGULATED EXPRESSION OF SHP-1 IN BURKITT-LYMPHOMAS AND GERMINAL CENTER B-LYMPHOCYTES", The Journal of experimental medicine, 186(9), 1997, pp. 1575-1583
26. DOODY GM; DEMPSEY PW; FEARON DT
    ACTIVATION OF B-LYMPHOCYTES - INTEGRATING SIGNALS FROM CD19, CD22 ANDFC-GAMMA-RIIB1
    Current opinion in immunology
    
    G.M. Doody et al., "ACTIVATION OF B-LYMPHOCYTES - INTEGRATING SIGNALS FROM CD19, CD22 ANDFC-GAMMA-RIIB1", Current opinion in immunology, 8(3), 1996, pp. 378-382
27. DEMPSEY PW; FEARON DT
    COMPLEMENT - INSTRUCTING THE ACQUIRED IMMUNE-SYSTEM THROUGH THE CD21 CD19 COMPLEX/
    Research in immunology
    
    P.W. Dempsey e D.T. Fearon, "COMPLEMENT - INSTRUCTING THE ACQUIRED IMMUNE-SYSTEM THROUGH THE CD21 CD19 COMPLEX/", Research in immunology, 147(2), 1996, pp. 71-75
28. FEARON DT; LOCKSLEY RM
    ELEMENTS OF IMMUNITY - THE INSTRUCTIVE ROLE OF INNATE IMMUNITY IN THEACQUIRED IMMUNE-RESPONSE
    Science
    
    D.T. Fearon e R.M. Locksley, "ELEMENTS OF IMMUNITY - THE INSTRUCTIVE ROLE OF INNATE IMMUNITY IN THEACQUIRED IMMUNE-RESPONSE", Science, 272(5258), 1996, pp. 50-54
29. DEMPSEY PW; ALLISON MED; AKKARAJU S; GOODNOW CC; FEARON DT
    C3D OF COMPLEMENT AS A MOLECULAR ADJUVANT - BRIDGING INNATE AND ACQUIRED-IMMUNITY
    Science
    
    P.W. Dempsey et al., "C3D OF COMPLEMENT AS A MOLECULAR ADJUVANT - BRIDGING INNATE AND ACQUIRED-IMMUNITY", Science, 271(5247), 1996, pp. 348-350
30. KROP I; SHAFFER AL; FEARON DT; SCHLISSEL MS
    THE SIGNALING ACTIVITY OF MURINE CD19 IS REGULATED DURING B-CELL DEVELOPMENT
    The Journal of immunology
    
    I. Krop et al., "THE SIGNALING ACTIVITY OF MURINE CD19 IS REGULATED DURING B-CELL DEVELOPMENT", The Journal of immunology, 157(1), 1996, pp. 48-56
31. ROLINK A; TENBOEKEL E; MELCHERS F; FEARON DT; KROP I; ANDERSSON J
    A SUBPOPULATION OF B220(-MARROW DOES NOT EXPRESS CD19 AND CONTAINS NATURAL-KILLER-CELL PROGENITORS() CELLS IN MURINE BONE)
    The Journal of experimental medicine
    
    A. Rolink et al., "A SUBPOPULATION OF B220(-MARROW DOES NOT EXPRESS CD19 AND CONTAINS NATURAL-KILLER-CELL PROGENITORS() CELLS IN MURINE BONE)", The Journal of experimental medicine, 183(1), 1996, pp. 187-194
32. FEARON DT
    HOW B-LYMPHOCYTES DETERMINE THE BIOLOGICAL RELEVANCE OF AN ANTIGEN
    Immunology
    
    D.T. Fearon, "HOW B-LYMPHOCYTES DETERMINE THE BIOLOGICAL RELEVANCE OF AN ANTIGEN", Immunology, 89, 1996, pp. 83-83
33. KROP I; DEFOUGEROLLES AR; HARDY RR; ALLISON M; SCHLISSEL MS; FEARON DT
    SELF-RENEWAL OF B-1 LYMPHOCYTES IS DEPENDENT ON CD19
    European Journal of Immunology
    
    I. Krop et al., "SELF-RENEWAL OF B-1 LYMPHOCYTES IS DEPENDENT ON CD19", European Journal of Immunology, 26(1), 1996, pp. 238-242
34. HINSHELWOOD S; ASIMAKOPOULOS FA; GILBERT JGR; DELIBRIAS CC; GOTTGENS B; FEARON DT; GREEN AR
    THE GENE ENCODING HEMATOPOIETIC-CELL, PHOSPHATASE (SHP-1) IS STRUCTURALLY AND TRANSCRIPTIONALLY INTACT POLYCYTHEMIA-VERA
    Blood
    
    S. Hinshelwood et al., "THE GENE ENCODING HEMATOPOIETIC-CELL, PHOSPHATASE (SHP-1) IS STRUCTURALLY AND TRANSCRIPTIONALLY INTACT POLYCYTHEMIA-VERA", Blood, 88(10), 1996, pp. 373-373
35. SANDOVAL DM; FEARON DT; CARTER RH
    ASSOCIATION OF VAV WITH CD19 AFTER IGM STIMULATION IS REQUIRED FOR CD19 IGM SYNERGY/
    Arthritis and rheumatism
    
    D.M. Sandoval et al., "ASSOCIATION OF VAV WITH CD19 AFTER IGM STIMULATION IS REQUIRED FOR CD19 IGM SYNERGY/", Arthritis and rheumatism, 39(9), 1996, pp. 24-24
36. FEARON DT
    THE B-LYMPHOCYTE AS AN IMMUNOTHERAPEUTIC TARGET
    Quarterly Journal of Medicine
    
    D.T. Fearon, "THE B-LYMPHOCYTE AS AN IMMUNOTHERAPEUTIC TARGET", Quarterly Journal of Medicine, 88(3), 1995, pp. 149-153
37. CARTER RH; DOODY G; BOLEN J; FEARON DT
    CD19 ASSOCIATES WITH THE B-CELL ANTIGEN RECEPTOR BY THE MEMBRANE-PROXIMAL CYTOPLASMIC DOMAIN
    The FASEB journal
    
    R.H. Carter et al., "CD19 ASSOCIATES WITH THE B-CELL ANTIGEN RECEPTOR BY THE MEMBRANE-PROXIMAL CYTOPLASMIC DOMAIN", The FASEB journal, 9(4), 1995, pp. 770-770
38. FEARON DT; CARTER RH
    THE CD19 CR2/TAPA-1 COMPLEX OF B-LYMPHOCYTES - LINKING NATURAL TO ACQUIRED-IMMUNITY/
    Annual review of immunology
    
    D.T. Fearon e R.H. Carter, "THE CD19 CR2/TAPA-1 COMPLEX OF B-LYMPHOCYTES - LINKING NATURAL TO ACQUIRED-IMMUNITY/", Annual review of immunology, 13, 1995, pp. 127-149
39. CROOKS MEC; LITTMAN DR; CARTER RH; FEARON DT; WEISS A; STEIN PH
    CD28-MEDIATED COSTIMULATION IN THE ABSENCE OF PHOSPHATIDYLINOSITOL 3-KINASE ASSOCIATION AND ACTIVATION
    Molecular and cellular biology
    
    M.E.C. Crooks et al., "CD28-MEDIATED COSTIMULATION IN THE ABSENCE OF PHOSPHATIDYLINOSITOL 3-KINASE ASSOCIATION AND ACTIVATION", Molecular and cellular biology, 15(12), 1995, pp. 6820-6828
40. DOODY GM; JUSTEMENT LB; DELIBRIAS CC; MATTHEWS RJ; LIN JJ; THOMAS ML; FEARON DT
    A ROLE IN B-CELL ACTIVATION FOR CD22 AND THE PROTEIN-TYROSINE-PHOSPHATASE SHP
    Science
    
    G.M. Doody et al., "A ROLE IN B-CELL ACTIVATION FOR CD22 AND THE PROTEIN-TYROSINE-PHOSPHATASE SHP", Science, 269(5221), 1995, pp. 242-244
41. WEINTRAUB H; ASHBURNER M; GOODFELLOW PN; LODISH HF; ARNTZEN CJ; ANDERSON PW; RICE TM; GEBALLE TH; MEANS AR; RANNEY HM; CECH TR; COLWELL RR; BOURNE HR; RICHTER B; SINGER IM; MARRACK P; FEARON DT; PENZIAS A; BARD AJ; BRINKMAN WF; MARKS PA; VOGELSTEIN B; KINZLER KW; BISHOP JM; ZARE RN; SCHATZ G; BENKOVIC SJ; GRAY HB; VALENTINE JS; CRUTZEN PJ; CHOI DW; NAKANISHI S; KOSSLYN SM; BRAUMAN JI; REES DC; BRILL WJ; SCHELL J; LUHRMANN R; WILL CL; WULF W; VERMEIJ GJ; ARROW KJ; SMELSER NJ; ANDERSON DL; ABELSON PH
    THROUGH THE GLASS LIGHTLY
    Science
    
    H. Weintraub et al., "THROUGH THE GLASS LIGHTLY", Science, 267(5204), 1995, pp. 1609-1618
42. BROWN E; ATKINSON JP; FEARON DT
    INNATE IMMUNITY - 50 WAYS TO KILL A MICROBE
    Current opinion in immunology
    
    E. Brown et al., "INNATE IMMUNITY - 50 WAYS TO KILL A MICROBE", Current opinion in immunology, 6(1), 1994, pp. 73-74
43. KALLI KR; HSU P; FEARON DT
    THERAPEUTIC USES OF RECOMBINANT COMPLEMENT PROTEIN INHIBITORS
    Perspectives in mathematical logic
    
    K.R. Kalli et al., "THERAPEUTIC USES OF RECOMBINANT COMPLEMENT PROTEIN INHIBITORS", Perspectives in mathematical logic, 15(4), 1994, pp. 417-431
44. KALLI KR; FEARON DT
    BINDING OF C3B AND C4B BY THE CR-1-LIKE SITE IN MURINE CR-1
    The Journal of immunology
    
    K.R. Kalli e D.T. Fearon, "BINDING OF C3B AND C4B BY THE CR-1-LIKE SITE IN MURINE CR-1", The Journal of immunology, 152(6), 1994, pp. 2899-2903
45. FEARON DT
    THE CD19-CR-2-TAPA-1 COMPLEX, CD45 AND SIGNALING BY THE ANTIGEN RECEPTOR OF B-LYMPHOCYTES
    Current opinion in immunology
    
    D.T. Fearon, "THE CD19-CR-2-TAPA-1 COMPLEX, CD45 AND SIGNALING BY THE ANTIGEN RECEPTOR OF B-LYMPHOCYTES", Current opinion in immunology, 5(3), 1993, pp. 341-348
46. TUVESON DA; CARTER RH; SOLTOFF SP; FEARON DT
    CD19 OF B-CELLS AS A SURROGATE KINASE INSERT REGION TO BIND PHOSPHATIDYLINOSITOL 3-KINASE
    Science
    
    D.A. Tuveson et al., "CD19 OF B-CELLS AS A SURROGATE KINASE INSERT REGION TO BIND PHOSPHATIDYLINOSITOL 3-KINASE", Science, 260(5110), 1993, pp. 986-989
47. DALPORTO J; JOHANSEN TE; CATIPOVIC B; PARFIIT DJ; TUVESON D; GETHER U; KOZLOWSKI S; FEARON DT; SCHNECK JP
    A SOLUBLE DIVALENT CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE INHIBITS ALLOREACTIVE T-CELLS AT NANOMOLAR CONCENTRATIONS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    J. Dalporto et al., "A SOLUBLE DIVALENT CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE INHIBITS ALLOREACTIVE T-CELLS AT NANOMOLAR CONCENTRATIONS", Proceedings of the National Academy of Sciences of the United Statesof America, 90(14), 1993, pp. 6671-6675
48. MOORE FD; HSU P; SIMPSON R; LINDSAY TF; HEBELL T; KOBZIK L; FEARON DT; HECHTMAN HB
    THE ALTERNATIVE PATHWAY MEDIATES COMPLEMENT ACTIVATION IN REPERFUSIONINJURY
    The Journal of immunology
    
    F.D. Moore et al., "THE ALTERNATIVE PATHWAY MEDIATES COMPLEMENT ACTIVATION IN REPERFUSIONINJURY", The Journal of immunology, 150(8), 1993, pp. 138-138
49. TUVESON DA; CARTER RH; SOLTOFF SP; FEARON DT
    CD19 - A SURROGATE KINASE INSERT DOMAIN THAT BINDS PHOSPHATIDYLINOSITIDYLINOSITOL 3-KINASE IN B-LYMPHOCYTES
    The Journal of immunology
    
    D.A. Tuveson et al., "CD19 - A SURROGATE KINASE INSERT DOMAIN THAT BINDS PHOSPHATIDYLINOSITIDYLINOSITOL 3-KINASE IN B-LYMPHOCYTES", The Journal of immunology, 150(8), 1993, pp. 254-254
50. MATSUMOTO AK; MARTIN DR; CARTER RH; KLICKSTEIN LB; AHEARN JM; FEARON DT
    FUNCTIONAL DISSECTION OF THE CD21 CD19/TAPA-1/LEU-13 COMPLEX OF B-LYMPHOCYTES/
    The Journal of experimental medicine
    
    A.K. Matsumoto et al., "FUNCTIONAL DISSECTION OF THE CD21 CD19/TAPA-1/LEU-13 COMPLEX OF B-LYMPHOCYTES/", The Journal of experimental medicine, 178(4), 1993, pp. 1407-1417